I'm looking for

All News

Improved OS for Patients With HER2-Positive Uterine Serous Carcinoma Receiving Trastuzumab Plus Chemotherapy

SGO in the News
Mar 30, 2020
Advertisement

Advertise With Us
Related Content
May 25, 2022Eisai Adds All Indicated Doses to Lenvatinib Dose Exchange Program After Research Presented at SGO 2022 Annual Meeting
Apr 27, 2020Herceptin Boosts OS in HER2-Positive Uterine Cancer
Apr 27, 2020Add-On Metformin No Help in Advanced Endometrial Cancer
Apr 13, 2020Frontline Niraparib Plus Bevacizumab for Advanced Ovarian Cancer Yields Promising Activity

Gynecologic Oncology News Updates

Stay up to date on the latest news from SGO and news from the industry. If you’re a member, make sure your account is signed up for these updates. If you’re not a member, contact us and we’ll add you to our list.

Request News Updates